Fennec Pharmaceuticals (FENC) Cash & Equivalents (2009 - 2026)
Fennec Pharmaceuticals' Cash & Equivalents came in at $41.25 million for Q2 2026, up 120.5% from $18.71 million a year earlier.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Fennec Pharmaceuticals' Cash & Equivalents was $36.79 million, up 38.1% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 3.9% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $26.63 million in FY2024 (+100.7%), $13.27 million in FY2023 (-44.2%), $23.77 million in FY2022 (+12.7%) and $21.1 million in FY2021 (-30.5%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents since Q2 2024.
- Year-over-year, Cash & Equivalents increased in four of the last seven quarters, with growth averaging 46.7%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2024 (growth of 225.2%), and the weakest in Q3 2023 (a decline of 58.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Fennec Pharmaceuticals | 370.66 Mn | 230.50 Mn | 17.15 Mn | 41.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.25 Mn |
| Mar 31, 2026 | 40.18 Mn |
| Dec 31, 2025 | 36.79 Mn |
| Sep 30, 2025 | 21.95 Mn |
| Jun 30, 2025 | 18.71 Mn |
| Mar 31, 2025 | 22.68 Mn |
| Dec 31, 2024 | 26.63 Mn |
| Sep 30, 2024 | 40.32 Mn |
| Jun 30, 2024 | 43.05 Mn |
| Mar 31, 2024 | 51.18 Mn |
| Dec 31, 2023 | 13.27 Mn |
| Sep 30, 2023 | 12.40 Mn |
| Jun 30, 2023 | 14.96 Mn |
| Mar 31, 2023 | 18.39 Mn |
| Dec 31, 2022 | 23.77 Mn |
| Sep 30, 2022 | 29.75 Mn |
| Jun 30, 2022 | 14.92 Mn |
| Mar 31, 2022 | 18.26 Mn |
| Dec 31, 2021 | 21.10 Mn |
| Sep 30, 2021 | 24.34 Mn |
API Access
Fennec Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=FENC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "FENC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=FENC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();